Artificial intelligence as a medical device is increasingly being applied to healthcare for
diagnosis, risk stratification and resource allocation. However, a growing body of evidence has …

To the Editor—As of June 2022, a wide range of Artificial Intelligence (AI) as a Medical Device
(AIaMDs) have received regulatory clearance internationally, with at least 343 devices …

Objective To identify research priorities for Anaesthesia and Perioperative Medicine. Design
Prospective surveys and consensus meetings guided by an independent adviser. Setting …

Objective To determine if margin involvement is associated with distant recurrence and to
determine the required margin to minimise both local recurrence and distant recurrence in …

Introduction Older patients with early breast cancer (EBC) derive modest survival benefit
from chemotherapy but have increased toxicity risk. Data on the impact of chemotherapy for …

Background Age-related breast cancer treatment variance is widespread with many older
women having primary endocrine therapy (PET), which may contribute to inferior survival and …

Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer
in older frailer women. Overall survival rates are equivalent although rates of local control …

Background Chemotherapy improves outcomes for high risk early breast cancer (EBC) patients
but is infrequently offered to older individuals. This study determined if there are fit older …

Background Rates of surgery and adjuvant therapy for breast cancer vary widely between
breast units. This may contribute to differences in survival. This cluster RCT evaluated the …

Introduction Recruitment and retention are two of the most important factors in successfully
running clinical trials. Many trials encounter problems with both, causing delays or preventing …